| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |